US Patent No. 9,073,852


Patent No. 9,073,852
Issue Date July 07, 2015
Title Salt Forms Of [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic Acid
Inventorship Joseph Francis Krzyzaniak, Pawcatuck, CT (US)
Jason Albert Leonard, New Rochelle, NY (US)
Assignee Pfizer Inc., New York, NY (US)

Claim of US Patent No. 9,073,852

1. An atorvastatin morpholine having an x-ray powder diffraction pattern containing the following 2? peaks measured using
CuK? radiation: 9.7, 16.0, 18.9, 19.6, 20.8, 22.1, 23.9, and 25.0, or a solid state 19F nuclear magnetic resonance having the following chemical shifts expressed in parts per million: ?117.6.